Volume 103, Issue 12 , Pages 1199-1201, December 2009
Mode of action and choice of antimalarial drugs for intermittent preventive treatment in infants☆
Summary
Intermittent preventive treatment in infants (IPTi) is an effective and safe malaria control strategy. However, it remains unclear what antimalarials should be used to replace sulfadoxine-pyrimethamine (SP) when and where SP is no longer an effective drug for IPTi. Work recently conducted in Tanzania, combined with the findings of previous studies, indicates that IPTi is essentially intermittent chemoprophylaxis; consequently, long-acting antimalarials that provide a long period of post-treatment prophylaxis will be the most effective alternative to SP. However, because of concerns about development of drug resistance, new combinations of long-acting drugs are urgently needed.
Keywords: Malaria, Intermittent preventive treatment, Sulfadoxine-pyrimethamine, Drug resistance, Chemoprophylaxis, Africa
To access this article, please choose from the options below
☆ Based on a presentation to the Royal Society of Tropical Medicine & Hygiene Research in Progress meeting on 18 December 2008. This oral presentation was awarded third prize at the meeting.
PII: S0035-9203(09)00201-6
doi:10.1016/j.trstmh.2009.06.007
© 2009 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Inc. All rights reserved.
Volume 103, Issue 12 , Pages 1199-1201, December 2009
